Free Trial

Tango Therapeutics (TNGX) Insider Trading & Ownership

Tango Therapeutics logo
$3.47 -0.05 (-1.42%)
(As of 12/5/2024 ET)

Tango Therapeutics (NASDAQ:TNGX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$74,000.00
Number Of
Insiders Selling
(Last 12 Months)
13
Amount Of
Insider Selling
(Last 12 Months)
$40.27 M
Get TNGX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tango Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TNGX Insider Buying and Selling by Quarter

Tango Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/18/2024Mace RothenbergDirectorBuy10,000$3.78$37,800.00  
11/14/2024Mace RothenbergDirectorBuy10,000$3.62$36,200.00  
11/6/2024Boxer Capital Management, LlcInsiderSell3,080,000$3.14$9,671,200.00  
10/25/2024Boxer Capital Management, LlcInsiderSell633,000$6.87$4,348,710.00  
10/21/2024Boxer Capital Management, LlcInsiderSell625,000$7.05$4,406,250.00  
9/13/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell67,400$10.53$709,722.00  
9/5/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell75,000$11.56$867,000.00  
8/30/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell175,000$11.60$2,030,000.00  
8/27/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell25,000$11.55$288,750.00  
8/19/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell150,000$10.09$1,513,500.00  
8/16/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell135,000$9.79$1,321,650.00  
8/1/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell40,000$9.80$392,000.00  
7/24/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell200,000$9.82$1,964,000.00  
7/22/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell262,740$9.78$2,569,597.20  
7/17/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell550,171$9.79$5,386,174.09  
7/1/2024Mva Investors, LlcInsiderSell110,731$8.87$982,183.97  
6/28/2024Mva Investors, LlcInsiderSell29,000$8.57$248,530.00  
6/6/2024Mva Investors, LlcInsiderSell63,000$7.24$456,120.00  
5/3/2024Mva Investors, LlcInsiderSell60,000$7.61$456,600.00  
5/1/2024Mva Investors, LlcInsiderSell75,000$7.43$557,250.00  
2/20/2024Rock Ventures Iv L.P. ThirdMajor ShareholderSell162,500$12.00$1,950,000.00  
2/7/2024Douglas BarryGeneral CounselSell1,354$12.62$17,087.48  
2/6/2024Adam CrystalInsiderSell4,288$12.56$53,857.28  
2/6/2024Barbara WeberCEOSell4,681$12.56$58,793.36  
2/6/2024Daniella BeckmanCFOSell1,908$12.56$23,964.48  
(Data available from 1/1/2013 forward)

TNGX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Tango Therapeutics includes Adam Crystal, Barbara Weber, Boxer Capital Management, Llc, Boxer Capital, Llc, Daniella Beckman, Douglas Barry, Mace Rothenberg, Mva Investors, Llc, and Rock Ventures Iv L.P. Third. Learn more on insiders at TNGX.

6.30% of Tango Therapeutics stock is owned by insiders. Learn more on TNGX's insider holdings.

The following insiders have purchased TNGX shares in the last 24 months: Boxer Capital, Llc ($11,168,750.00), and Mace Rothenberg ($74,000.00).

Insiders have purchased a total of 1,745,000 TNGX shares in the last 24 months for a total of $11,242,750.00 bought.

The following insiders have sold TNGX shares in the last 24 months: Adam Crystal ($116,841.01), Barbara Weber ($58,793.36), Boxer Capital Management, Llc ($18,426,160.00), Boxer Capital, Llc ($1,744,750.00), Daniella Beckman ($23,964.48), Douglas Barry ($17,087.48), Mva Investors, Llc ($2,700,683.97), and Rock Ventures Iv L.P. Third ($18,992,393.29).

Insiders have sold a total of 6,713,280 Tango Therapeutics shares in the last 24 months for a total of $42,080,673.59 sold.

Tango Therapeutics Key Executives

  • Dr. Barbara L. Weber M.D. (Age 67)
    President, CEO & Director
    Compensation: $1.04M
  • Dr. Adam S. Crystal M.D. (Age 47)
    Ph.D., President of Research & Development
    Compensation: $977.22k
  • Dr. Alan Ashworth FRS (Age 63)
    Ph.D., Founder & Member of Scientific Advisory Board
  • Dr. Levi Garraway M.D. (Age 55)
    Ph.D., Founder
  • Dr. William G. Kaelin Jr. (Age 66)
    M.D., Founder & Member of Scientific Advisory Board
  • Dr. Timothy K. Lu M.D. (Age 43)
    Ph.D., Founder
  • Dr. Antoni Ribas M.D. (Age 57)
    Ph.D., Founder & Member of Scientific Advisory Board
  • Mr. Timothy Redfern (Age 45)
    Chief Financial Officer
  • Mr. Jannik N. Andersen Ph.D.
    Chief Scientific Officer
  • Mr. Douglas J. Barry Esq. (Age 54)
    J.D., Chief Legal Officer, Chief Compliance Officer & Corporate Secretary


This page (NASDAQ:TNGX) was last updated on 12/6/2024 by MarketBeat.com Staff
From Our Partners